Performance of prothrombin-proconvertin time as a monitoring test of oral anticoagulation therapy.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsHaraldsson, H M
Onundarson, P T
Einarsdottir, K A
Gudmundsdottir, B R
Petursson, M K
MetadataShow full item record
CitationAm. J. Clin. Pathol. 1997, 107(6):672-80
AbstractOutcome and anticoagulation intensity was evaluated during 121 patient years of oral anticoagulant therapy monitored with the prothrombin-proconvertin clotting time (PP, also known as P&P). The PP-based international normalized ratio (INR; PP-INR) correlated well with the INR calculated from the prothrombin clotting time (PT; r = 0.92), and results were almost identical over a wide range after linear conversion (1/INR). When the PP-INR was 4.5 or less, the risk of major bleeding was 1 for every 118 treatment years, but it was 1 for every 73 days when the INR was 6 or more. The 1/PP-INR correlated better with factor II coagulant activity (r = 0.85) than did the 1/PT-INR (r = 0.78). The 1/PP-INR also correlated better with the native prothrombin antigen (r = 0.76) than did the 1/PT-INR (r = 0.68). The PP and PT results correlated better with factor II coagulant activity than with native prothrombin antigen. Thus, the PP clotting time results can be accurately converted to INR. The results also suggest that the PP may have advantages over the PT as an indicator of anticoagulation intensity during oral anticoagulation.
- During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.
- Authors: Jonsson PI, Letertre L, Juliusson SJ, Gudmundsdottir BR, Francis CW, Onundarson PT
- Issue date: 2017 Jan
- The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods.
- Authors: Le DT, Weibert RT, Sevilla BK, Donnelly KJ, Rapaport SI
- Issue date: 1994 Apr 1
- Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
- Authors: Onundarson PT, Francis CW, Indridason OS, Arnar DO, Bjornsson ES, Magnusson MK, Juliusson SJ, Jensdottir HM, Vidarsson B, Gunnarsson PS, Lund SH, Gudmundsdottir BR
- Issue date: 2015 Jun
- Comparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long-term warfarin therapy and those in the initial phase.
- Authors: Weinstock DM, Chang P, Aronson DL, Kessler CM
- Issue date: 1998 Mar
- D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
- Authors: Yamamoto R, Nakae Y, Tanaka F, Johkura K
- Issue date: 2016 Jul